GlassScriptPhysician profile
Maheedhar Gedela
NPI 1104231216
$54,301.02
in general payments reported to CMS, 2019-2025
36 companies · $9,579 in 2025
The $9,579 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,374 · 2020: $3,681 · 2021: $18K · 2022: $4,918 · 2023: $3,455 · 2024: $10K · 2025: $9,579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,024 · Food and Beverage: $8,070 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,024.39 |
| Food and Beverage | $8,070.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $27,171.51 | 2021-2025 | Corevalve Evolut R, Micra, Onyx Frontier |
| Abbott Laboratories | $8,595.10 | 2019-2025 | Triclip, Mitraclip, Optis |
| Edwards Lifesciences Corporation | $3,505.12 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $1,996.36 | 2020-2025 | Impella |
| Medtronic Vascular, INC. | $1,915.61 | 2019-2020 | |
| Philips North America LLC | $1,849.99 | 2020-2024 | (Bs3) Intracardiac Und, (Ao0) Igt Devices Intracardiac |
| Boston Scientific Corporation | $1,181.05 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Clinical Trial Product |
| Cardiovascular Systems INC. | $1,081.62 | 2020-2022 | |
| Shockwave Medical, INC | $947.98 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $680.17 | 2019-2025 | Lifevest |
| Amgen INC. | $672.27 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $553.43 | 2020-2025 | Wainua, Farxiga |
| Chiesi USA, INC. | $550.58 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $521.86 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $431.97 | 2020-2024 | Camzyos |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $424.44 | 2020-2022 | |
| Pfizer INC. | $407.61 | 2020-2024 | |
| Biotronik INC. | $350.71 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $259.58 | 2020 | |
| Astellas Pharma US INC | $189.90 | 2019 | |
| Acist Medical Systems, INC. | $164.52 | 2022-2023 | |
| Cordis US Corp. | $133.42 | 2021 | |
| Biosense Webster, INC. | $119.63 | 2025 | Nuvision Ice Catheter |
| Novartis Pharmaceuticals Corporation | $97.79 | 2024-2025 | |
| Cardiva Medical, INC. | $91.14 | 2020-2021 | |
| Teleflex LLC | $90.37 | 2021-2022 | |
| Heartflow, INC. | $57.01 | 2019 | |
| Asahi Intecc USA, INC. | $49.55 | 2022 | |
| Penumbra, INC. | $48.50 | 2021 | |
| Getinge USA Sales, LLC | $38.10 | 2020 | |
| Cardinal Health 200 LLC | $28.06 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $27.35 | 2020 | |
| W. L. Gore & Associates, INC. | $24.47 | 2021 | |
| Vifor Pharma, INC. | $16.89 | 2019 | |
| Cardiofocus, INC. | $14.82 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maheedhar Gedela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.